In silico Identification of the HLA-DRB1*15:01 Restricted B-cell and T-cell Epitopes of the Autoantigens MOG and AQP4 Associated with Autoimmune Neuropathy
Main Article Content
Abstract
Immunogenicity plays a crucial role in the pathogenesis of autoimmune neuropathy associated with MOG and AQP4 proteins. Hence, we employed computational tools, including MHC-II Binding Prediction and B Cell Epitope Prediction tools from IEDB, Clustal Omega, SWISS-MODEL, AbodyBuilder, HDOCK, AlphaFold Protein Structure Database, and Protein Data Bank, to identify potential HLA-DRB1*15:01 restricted T-cell and B-cell epitopes of the autoantigens MOG and AQP4 and their structural characteristics. Subsequently, the peptide sequences of bacterial proteins identical to the epitopes of MOG and AQP4 proteins were analyzed using BLASTp, MoRFchibi SYSTEM, IUPred3, SEG, miPepBase, and NCBI databases to detect the presence of MoRF, SliM, and LCR. Our findings revealed that MOG22-LQVSSSY-28, MOG80-YRNGKD-85, MOG179-QYRLRGKL-186 and AQP475-CTRKIS-80 were common sequences of the HLA-DRB1*15:01 restricted T-cell and B-cell epitopes of the autoantigens MOG and AQP4. While MoRFs and LCRs were found in some bacteria, the prevalence was low (10.81% and 5.40%, respectively). This suggests that these bacteria may not use the identical peptides to regulate protein-protein interactions and host cell activities.
Keywords:
Epitope, MOG, AQP4, HLA-DRB1*15:01, autoimmune neuropathy
References
[1] A. Davidson, B. Diamond, Autoimmune Diseases, The New England Journal of Medicine, Vol. 345, No. 5, 2001, pp. 340-350, https://doi.org/10.1056/NEJM 200108023450506.
[2] D. Whittam, M. Wilson, S. Hamid, G. Keir, M. Bhojak, A. Jacob, What’s New in Neuromyelitis Optica? A Short Review for the Clinical Neurologist, Journal of Neurology, Vol. 264, No. 11, 2017, pp. 2330-2344,
https://doi.org/10.1007/s00415-017-8445-8.
[3] D. G. Brum, A. A. Barreira, A. C. dos Santos, D. R. Kaimen-Maciel, M. Matiello, R. M. Costa, N. H. Deghaide, L. S. Costa, P.L ouzada-Junior, P. R. Diniz, E. R. Comini-Frota, C. T. Mendes-Junior, E. A. Donadi, HLA-DRB Association in Neuromyelitis Optica is Different from that Observed in Multiple Sclerosis, Multiple Sclerosis (Houndmills, Basingstoke, England), Vol. 16, No. 1, 2010, pp. 21-29, https://doi.org/10.1177/1352458509350741.
[4] M. Matiello, J. Schaefer-Klein, D. G. Brum, E. J. Atkinson, O. H. Kantarci, B. G. Weinshenker, NMO genetics collaborators, HLA-DRB1*1501 Tagging rs3135388 Polymorphism is not Associated with Neuromyelitis Optica, Multiple Sclerosis (Houndmills, Basingstoke, England), Vol. 16, No. 8, 2010, pp. 981-984,
https://doi.org/10.1177/1352458510 374340.
[5] R. Kogay, C. Schönbach, Epitope Predictions, in Encyclopedia of Bioinformatics and Computational Biology, Elsevier, 2019, pp. 952-971.
[6] M. Rojas, P. R. Jiménez, D. M. Monsalve, Y. Pacheco, Y. A. Ampudia, C. R. Santana, P. S. C. Leung, A. A. Ansari, M. E. Gershwin, J. M. Anaya, Molecular Mimicry and Autoimmunity, Journal of Autoimmunity, Vol. 95, 2018, pp. 100-123, https://doi.org/10.1016/j.jaut.2018. 10.012.
[7] R. van der Lee, M. Buljan, B. Lang, R. J. Weatheritt, G. W. Daughdrill, A. K. Dunker, M. Fuxreiter, J. Gough, J. Gsponer, D. T. Jones, P. M. Kim, R. W. Kriwacki, C. J. Oldfield, R. V. Pappu, P. Tompa, V. N. Uversky, P. E. Wright, M. M. Babu, Classification of Intrinsically Disordered Regions and Proteins, Chemical Reviews, Vol. 114, No.13, 2014, pp. 6589-6631, https://doi.org/10.1021/ cr400525m.
[8] A. Mohan, C. J. Oldfield, P. Radivojac, V. Vacic, M. S. Cortese, A. K. Dunker, V. N. Uversky, Analysis of Molecular Recognition Features (MoRFs), Journal of Molecular Biology, Vol. 362, No. 5, 2006, pp. 1043-1059, https://doi.org/10.1016/ j.jmb.2006.07.087.
[9] N. E. Davey, G. Travé, T. J. Gibson, How Viruses Hijack Cell Regulation, Trends in Biochemical Sciences, Vol. 36, No. 3, 2011, pp. 159-169, https://doi.org/10.1016/j.tibs.2010.10.002.
[10] K. Tunyasuvunakool, J. Adler, Z. Wu, T. Green, M. Zielinski, A. Žídek, A. Bridgland, A. Cowie, C. Meyer, A. Laydon, S. Velankar, G. J. Kleywegt, A. Bateman, R. Evans, A. Pritzel, M. Figurnov, O. Ronneberger,
R. Bates, S. A. A. Kohl, A. Potapenko, D. Hassabis, Highly Accurate Protein Structure Prediction with AlphaFold, Nature, Vol. 596, No. 7873, 2021, pp. 583-589, https://doi.org/10.1038/s41586-021-03828-1.
[11] H. M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T. N. Bhat, H. Weissig, I. N. Shindyalov, P. E. Bourne, The Protein Data Bank, Nucleic Acids Research, Vol. 28, No. 1, 2000, pp. 235-242, https://doi.org/10.1093/nar/28.1.235.
[12] P. Waters, M. Woodhall, K. C. O'Connor, M. Reindl, B. Lang, D. K. Sato, M. Juryńczyk, G. Tackley, J. Rocha, T. Takahashi, T., Misu, I. Nakashima, J. Palace, K. Fujihara, M. I. Leite, A. Vincent, MOG Cell-based Assay Detects Non-MS Patients with Inflammatory Neurologic Disease, Neurology(R) Neuroimmunology & Neuroinflammation,
Vol. 2, No. 3, 2015, pp. e89, https://doi.org/10.1212/NXI.0000000000000089.
[13] M. Reindl, P. Waters, Myelin Oligodendrocyte Glycoprotein Antibodies in Neurological Disease, Nature reviews. Neurology, Vol. 15, No. 2, 2019, pp. 89-102, https://doi.org/10.1038/s41582-018-0112-x.
[14] O. Schmetzer, E. Lakin, B. Roediger, A. Duchow, S. Asseyer, F. Paul, N. Siebert, Anti-aquaporin 4 IgG is Not Associated with Any Clinical Disease Characteristics in Neuromyelitis Optica Spectrum Disorder, Frontiers in Neurology, Vol. 12, No. 16, 2021, pp. 1-14, https://doi.org/10.3389/fneur.2021.635419.
[15] P. Saikali, R. Cayrol, and T. Vincent, Anti-aquaporin-4 Auto-antibodies Orchestrate the Pathogenesis in Neuromyelitis Optica, Autoimmunity Reviews, Vol. 9, No. 2, 2009, pp. 132-135, https://doi.org/10.1016/j.autrev.2009.04.004.
[16] C. A. Zhang, Z. Prachanronarong, K. Gellatly, K. Marasco, W.A. Schiffer, Antibody Fab Fragment, Worldwide PDB Protein Data Bank, Vol. 01, No. 2010, 2017, pp. 1-20, https://doi.org/10.2210/pdb5JQD/pdb.
[17] T. D. Goddard, C. C. Huang, E. C. Meng, E. F. Pettersen, G. S. Couch, J. H. Morris, T. E. Ferrin, UCSF ChimeraX: Meeting Modern Challenges in Visualization and Analysis, Protein Science, Vol. 27, 2018, pp. 14-25, https://doi.org/10. 1002/pro.3235.
[18] J. Neefjes, M. L. M. Jongsma, P. Paul, O. Bakke, Towards a Systems Understanding of MHC Class I and MHC Class II Antigen Presentation, Nature Reviews. Immunology, Vol. 11, No. 12, 2011, pp. 823-836, https://doi.org/10.1038/nri3084.
[19] Y. C. Chuang, Y. S. Lin, H. S. Liu, T. M. Yeh, Molecular Mimicry between Dengue Virus and Coagulation Factors Induces Antibodies to Inhibit Thrombin Activity and Enhance Fibrinolysis, Journal of Virology, Vol. 88, No. 23, 2014, pp. 13759-13768, https://doi.org/10.1128/JVI.02166-14.
[20] J. L. Grogan, A. Kramer, A. Nogai, L. Dong, M. Ohde, J. S. Mergener, T. Kamradt, Cross-reactivity of Myelin Basic Protein-specific T Cells with Multiple Microbial Peptides: Experimental Autoimmune Encephalomyelitis Induction in TCR Transgenic Mice, Journal of Immunology, Vol. 163, No. 7, 1999, pp. 3764-3770.
[21] F. C. Westall, Molecular Mimicry Revisited: Gut Bacteria and Multiple Sclerosis, Journal of Clinical Microbiology, Vol. 44, No. 6, 2006, pp. 2099-2104, https://doi.org/10.1128/JCM.02532-05.
[22] J. S. Blum, P. A. Wearsch, P. Cresswell, Pathways of Antigen Processing, Annual Review of Immunology, No. 31, 2013, pp. 443-473, https://doi.org/10.1146/annurev-immunol-032712-095910.
[23] B. Hemmer, T. Kondo, B. Gran, C. Pinilla, I. Cortese, J. Pascal, A. Tzou, H. F. McFarland, R. Houghten, R. Martin, Minimal Peptide Length Requirements for CD4(+) T Cell Clones--implications for Molecular Mimicry and T Cell Survival, International Immunology, Vol. 12, No. 3, 2000, pp. 375-383, https://doi.org/10.1093/intimm/12.3.375.
[24] N. Borthwick, S. S. Arrieta, A. Llano, M. Takiguchi, C. Brander, T. Hanke, Novel Nested Peptide Epitopes Recognized by CD4 + T Cells Induced by HIV-1 Conserved-Region Vaccines, Vaccines, Vol. 8, No. 1, 2020, pp. 28, https://doi.org/10.3390/vaccines8010028.
[25] H. Singh, H. R. Ansari, G. P. S. Raghava, Improved Method for Linear B-cell Epitope Prediction Using Antigen's Primary Sequence, PLoS One, Vol. 8, No. 5, 2013, pp. 1-8, https://doi.org/10.1371/journal.pone.0062216.
[26] G. Ofek, M. Tang, A. Sambor, H. Katinger, J. R. Mascola, R. Wyatt, P. D. Kwong, Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope, Journal of Virology, Vol. 78, No. 19, 2004, pp. 10724-10737, https://doi.org/10.1128/JVI.78.19.10724-10737.2004.
[27] N. K. D. Rosb, M. Hoffman, I. Mendel, I. Yust, J. Kaye, R. Bakimer, S. Flechter, O. Abramsky, R. Milo, A. Karni, A. B. Nun, Predominance of the Autoimmune Response to Myelin Oligodendrocyte Glycoprotein (MOG) in Multiple Sclerosis: Reactivity to the Extracellular Domain of MOG is Directed Against Three Main Regions, European Journal of Immunology, Vol. 27, No. 11, 1997, pp. 3059-3069, https://doi.org/10.1002/eji. 1830271144.
[28] E. Wallstrom, M. Khademi, M. Andersson, R. Weissert, C. Linington, T. Olsson, Increased Reactivity to Myelin Oligodendrocyte Glycoprotein Peptides and Epitope Mapping in HLA DR2(15)+ Multiple Sclerosis, European Journal of Immunology, Vol. 28, No. 10, 1998, pp. 3329-3335, https://doi.org/10.1002/(SICI)1521-4141(199810) 28:10<3329::AID-IMMU3329>3.0.CO;2-B.
[29] R. Weissert, J. Kuhle, K. L. de Graaf, W. Wienhold, M. M. Herrmann, C. Müller, T. G. Forsthuber, K. H. Wiesmüller, A. Melms, High Immunogenicity of Intracellular Myelin Oligodendrocyte Glycoprotein Epitopes, Journal of Immunology (Baltimore, Md. : 1950, Vol. 169, No. 1, 2002, pp. 548-556, https://doi.org/10.4049/ jimmunol.169.1.548.
[30] L. S. Hofer, M. Ramberger, V. Gredler, A. S. Pescoller, K. Rostásy, M. Sospedra, H. Hegen, T. Berger, A. Lutterotti, M. Reindl, Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases, Frontiers in Immunology, Vol. 11, 2020, https://doi.org/10.3389/fimmu.2020.01188.
[31] N. Matsuya, M. Komori, K. Nomura, S. Nakane, T. Fukudome, H. Goto, H. Shiraishi, K. P. Wandinger, H. Matsuo, T. Kondo, Increased T-cell Immunity Against Aquaporin-4 and Proteolipid Protein in Neuromyelitis Optica, International Immunology, Vol. 23, No. 9, 2011, pp. 565-573, https:// doi.org/10.1093/intimm/dxr056.
[2] D. Whittam, M. Wilson, S. Hamid, G. Keir, M. Bhojak, A. Jacob, What’s New in Neuromyelitis Optica? A Short Review for the Clinical Neurologist, Journal of Neurology, Vol. 264, No. 11, 2017, pp. 2330-2344,
https://doi.org/10.1007/s00415-017-8445-8.
[3] D. G. Brum, A. A. Barreira, A. C. dos Santos, D. R. Kaimen-Maciel, M. Matiello, R. M. Costa, N. H. Deghaide, L. S. Costa, P.L ouzada-Junior, P. R. Diniz, E. R. Comini-Frota, C. T. Mendes-Junior, E. A. Donadi, HLA-DRB Association in Neuromyelitis Optica is Different from that Observed in Multiple Sclerosis, Multiple Sclerosis (Houndmills, Basingstoke, England), Vol. 16, No. 1, 2010, pp. 21-29, https://doi.org/10.1177/1352458509350741.
[4] M. Matiello, J. Schaefer-Klein, D. G. Brum, E. J. Atkinson, O. H. Kantarci, B. G. Weinshenker, NMO genetics collaborators, HLA-DRB1*1501 Tagging rs3135388 Polymorphism is not Associated with Neuromyelitis Optica, Multiple Sclerosis (Houndmills, Basingstoke, England), Vol. 16, No. 8, 2010, pp. 981-984,
https://doi.org/10.1177/1352458510 374340.
[5] R. Kogay, C. Schönbach, Epitope Predictions, in Encyclopedia of Bioinformatics and Computational Biology, Elsevier, 2019, pp. 952-971.
[6] M. Rojas, P. R. Jiménez, D. M. Monsalve, Y. Pacheco, Y. A. Ampudia, C. R. Santana, P. S. C. Leung, A. A. Ansari, M. E. Gershwin, J. M. Anaya, Molecular Mimicry and Autoimmunity, Journal of Autoimmunity, Vol. 95, 2018, pp. 100-123, https://doi.org/10.1016/j.jaut.2018. 10.012.
[7] R. van der Lee, M. Buljan, B. Lang, R. J. Weatheritt, G. W. Daughdrill, A. K. Dunker, M. Fuxreiter, J. Gough, J. Gsponer, D. T. Jones, P. M. Kim, R. W. Kriwacki, C. J. Oldfield, R. V. Pappu, P. Tompa, V. N. Uversky, P. E. Wright, M. M. Babu, Classification of Intrinsically Disordered Regions and Proteins, Chemical Reviews, Vol. 114, No.13, 2014, pp. 6589-6631, https://doi.org/10.1021/ cr400525m.
[8] A. Mohan, C. J. Oldfield, P. Radivojac, V. Vacic, M. S. Cortese, A. K. Dunker, V. N. Uversky, Analysis of Molecular Recognition Features (MoRFs), Journal of Molecular Biology, Vol. 362, No. 5, 2006, pp. 1043-1059, https://doi.org/10.1016/ j.jmb.2006.07.087.
[9] N. E. Davey, G. Travé, T. J. Gibson, How Viruses Hijack Cell Regulation, Trends in Biochemical Sciences, Vol. 36, No. 3, 2011, pp. 159-169, https://doi.org/10.1016/j.tibs.2010.10.002.
[10] K. Tunyasuvunakool, J. Adler, Z. Wu, T. Green, M. Zielinski, A. Žídek, A. Bridgland, A. Cowie, C. Meyer, A. Laydon, S. Velankar, G. J. Kleywegt, A. Bateman, R. Evans, A. Pritzel, M. Figurnov, O. Ronneberger,
R. Bates, S. A. A. Kohl, A. Potapenko, D. Hassabis, Highly Accurate Protein Structure Prediction with AlphaFold, Nature, Vol. 596, No. 7873, 2021, pp. 583-589, https://doi.org/10.1038/s41586-021-03828-1.
[11] H. M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T. N. Bhat, H. Weissig, I. N. Shindyalov, P. E. Bourne, The Protein Data Bank, Nucleic Acids Research, Vol. 28, No. 1, 2000, pp. 235-242, https://doi.org/10.1093/nar/28.1.235.
[12] P. Waters, M. Woodhall, K. C. O'Connor, M. Reindl, B. Lang, D. K. Sato, M. Juryńczyk, G. Tackley, J. Rocha, T. Takahashi, T., Misu, I. Nakashima, J. Palace, K. Fujihara, M. I. Leite, A. Vincent, MOG Cell-based Assay Detects Non-MS Patients with Inflammatory Neurologic Disease, Neurology(R) Neuroimmunology & Neuroinflammation,
Vol. 2, No. 3, 2015, pp. e89, https://doi.org/10.1212/NXI.0000000000000089.
[13] M. Reindl, P. Waters, Myelin Oligodendrocyte Glycoprotein Antibodies in Neurological Disease, Nature reviews. Neurology, Vol. 15, No. 2, 2019, pp. 89-102, https://doi.org/10.1038/s41582-018-0112-x.
[14] O. Schmetzer, E. Lakin, B. Roediger, A. Duchow, S. Asseyer, F. Paul, N. Siebert, Anti-aquaporin 4 IgG is Not Associated with Any Clinical Disease Characteristics in Neuromyelitis Optica Spectrum Disorder, Frontiers in Neurology, Vol. 12, No. 16, 2021, pp. 1-14, https://doi.org/10.3389/fneur.2021.635419.
[15] P. Saikali, R. Cayrol, and T. Vincent, Anti-aquaporin-4 Auto-antibodies Orchestrate the Pathogenesis in Neuromyelitis Optica, Autoimmunity Reviews, Vol. 9, No. 2, 2009, pp. 132-135, https://doi.org/10.1016/j.autrev.2009.04.004.
[16] C. A. Zhang, Z. Prachanronarong, K. Gellatly, K. Marasco, W.A. Schiffer, Antibody Fab Fragment, Worldwide PDB Protein Data Bank, Vol. 01, No. 2010, 2017, pp. 1-20, https://doi.org/10.2210/pdb5JQD/pdb.
[17] T. D. Goddard, C. C. Huang, E. C. Meng, E. F. Pettersen, G. S. Couch, J. H. Morris, T. E. Ferrin, UCSF ChimeraX: Meeting Modern Challenges in Visualization and Analysis, Protein Science, Vol. 27, 2018, pp. 14-25, https://doi.org/10. 1002/pro.3235.
[18] J. Neefjes, M. L. M. Jongsma, P. Paul, O. Bakke, Towards a Systems Understanding of MHC Class I and MHC Class II Antigen Presentation, Nature Reviews. Immunology, Vol. 11, No. 12, 2011, pp. 823-836, https://doi.org/10.1038/nri3084.
[19] Y. C. Chuang, Y. S. Lin, H. S. Liu, T. M. Yeh, Molecular Mimicry between Dengue Virus and Coagulation Factors Induces Antibodies to Inhibit Thrombin Activity and Enhance Fibrinolysis, Journal of Virology, Vol. 88, No. 23, 2014, pp. 13759-13768, https://doi.org/10.1128/JVI.02166-14.
[20] J. L. Grogan, A. Kramer, A. Nogai, L. Dong, M. Ohde, J. S. Mergener, T. Kamradt, Cross-reactivity of Myelin Basic Protein-specific T Cells with Multiple Microbial Peptides: Experimental Autoimmune Encephalomyelitis Induction in TCR Transgenic Mice, Journal of Immunology, Vol. 163, No. 7, 1999, pp. 3764-3770.
[21] F. C. Westall, Molecular Mimicry Revisited: Gut Bacteria and Multiple Sclerosis, Journal of Clinical Microbiology, Vol. 44, No. 6, 2006, pp. 2099-2104, https://doi.org/10.1128/JCM.02532-05.
[22] J. S. Blum, P. A. Wearsch, P. Cresswell, Pathways of Antigen Processing, Annual Review of Immunology, No. 31, 2013, pp. 443-473, https://doi.org/10.1146/annurev-immunol-032712-095910.
[23] B. Hemmer, T. Kondo, B. Gran, C. Pinilla, I. Cortese, J. Pascal, A. Tzou, H. F. McFarland, R. Houghten, R. Martin, Minimal Peptide Length Requirements for CD4(+) T Cell Clones--implications for Molecular Mimicry and T Cell Survival, International Immunology, Vol. 12, No. 3, 2000, pp. 375-383, https://doi.org/10.1093/intimm/12.3.375.
[24] N. Borthwick, S. S. Arrieta, A. Llano, M. Takiguchi, C. Brander, T. Hanke, Novel Nested Peptide Epitopes Recognized by CD4 + T Cells Induced by HIV-1 Conserved-Region Vaccines, Vaccines, Vol. 8, No. 1, 2020, pp. 28, https://doi.org/10.3390/vaccines8010028.
[25] H. Singh, H. R. Ansari, G. P. S. Raghava, Improved Method for Linear B-cell Epitope Prediction Using Antigen's Primary Sequence, PLoS One, Vol. 8, No. 5, 2013, pp. 1-8, https://doi.org/10.1371/journal.pone.0062216.
[26] G. Ofek, M. Tang, A. Sambor, H. Katinger, J. R. Mascola, R. Wyatt, P. D. Kwong, Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope, Journal of Virology, Vol. 78, No. 19, 2004, pp. 10724-10737, https://doi.org/10.1128/JVI.78.19.10724-10737.2004.
[27] N. K. D. Rosb, M. Hoffman, I. Mendel, I. Yust, J. Kaye, R. Bakimer, S. Flechter, O. Abramsky, R. Milo, A. Karni, A. B. Nun, Predominance of the Autoimmune Response to Myelin Oligodendrocyte Glycoprotein (MOG) in Multiple Sclerosis: Reactivity to the Extracellular Domain of MOG is Directed Against Three Main Regions, European Journal of Immunology, Vol. 27, No. 11, 1997, pp. 3059-3069, https://doi.org/10.1002/eji. 1830271144.
[28] E. Wallstrom, M. Khademi, M. Andersson, R. Weissert, C. Linington, T. Olsson, Increased Reactivity to Myelin Oligodendrocyte Glycoprotein Peptides and Epitope Mapping in HLA DR2(15)+ Multiple Sclerosis, European Journal of Immunology, Vol. 28, No. 10, 1998, pp. 3329-3335, https://doi.org/10.1002/(SICI)1521-4141(199810) 28:10<3329::AID-IMMU3329>3.0.CO;2-B.
[29] R. Weissert, J. Kuhle, K. L. de Graaf, W. Wienhold, M. M. Herrmann, C. Müller, T. G. Forsthuber, K. H. Wiesmüller, A. Melms, High Immunogenicity of Intracellular Myelin Oligodendrocyte Glycoprotein Epitopes, Journal of Immunology (Baltimore, Md. : 1950, Vol. 169, No. 1, 2002, pp. 548-556, https://doi.org/10.4049/ jimmunol.169.1.548.
[30] L. S. Hofer, M. Ramberger, V. Gredler, A. S. Pescoller, K. Rostásy, M. Sospedra, H. Hegen, T. Berger, A. Lutterotti, M. Reindl, Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases, Frontiers in Immunology, Vol. 11, 2020, https://doi.org/10.3389/fimmu.2020.01188.
[31] N. Matsuya, M. Komori, K. Nomura, S. Nakane, T. Fukudome, H. Goto, H. Shiraishi, K. P. Wandinger, H. Matsuo, T. Kondo, Increased T-cell Immunity Against Aquaporin-4 and Proteolipid Protein in Neuromyelitis Optica, International Immunology, Vol. 23, No. 9, 2011, pp. 565-573, https:// doi.org/10.1093/intimm/dxr056.